|1.||Iwashita, Y: 1 article (08/2007)|
|2.||Kitano, S: 1 article (08/2007)|
|3.||Goto, T: 1 article (08/2007)|
|4.||Shibata, K: 1 article (08/2007)|
|5.||Ohmori, N: 1 article (08/2007)|
|6.||Ohta, M: 1 article (08/2007)|
|7.||Sato, S: 1 article (08/2007)|
|8.||Tominaga, M: 1 article (08/2007)|
|9.||Ishio, T: 1 article (08/2007)|
|10.||Goto, Shigeru: 1 article (02/2004)|
08/01/2007 - "The aim of this study was to evaluate the antitumor effects of exogenous expression of the MIG and IP-10 genes delivered to solid tumors by poly [D,L-2,4-diaminobutyric acid] (PDBA). "
08/01/2007 - "In conclusion, PDBA-mediated MIG and IP-10 gene therapy may be useful for treatment of solid tumors."
08/01/2007 - "MIG and IP-10 gene therapy with the PDBA system in vivo significantly inhibited tumor growth and prolonged survival time of mice. "
08/01/2007 - "Tumors were injected in vivo with PDBA/pmMIGColon, two colonsIP-10 complexes to evaluate the effects of these genes on tumor volume and survival time of mice. "
02/01/2004 - "These results suggest that PDBA-mediated IL-12 gene therapy is a potential strategy for treatment of patients with solid tumors."
|1.||Interleukin-12 (IL 12)